| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/16/2001 | US6174678 Screening for bactericides that interact with enzymatic polypeptides; providing bacterial testing strains that are isogenic, incubating modulator, detecting sensitivity of bacteria to modulators |
| 01/16/2001 | US6174677 Advanced surface-enhanced Raman gene probe systems and methods thereof |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | US6174673 High throughput screening for novel enzymes |
| 01/16/2001 | US6174672 Monitoring polymerase activity in sample; preparing complex of magnetic particles and an immbolized primer/template, incubate complex with sample, incubate sample with label, screen for presence of polymerase |
| 01/16/2001 | US6174671 Genomics via optical mapping ordered restriction maps |
| 01/16/2001 | US6174670 Achieved with rapid thermal cycling and use of double stranded dna dyes or specific hybridization probes |
| 01/16/2001 | US6174668 Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures |
| 01/16/2001 | US6174666 Reducing adjustments in ribonucleic acid sequences; providing gene coding transcription products, detect regulatory sequences, insert point mutations, transfect mutated gene into cells, culture cells and monitoring gene expression |
| 01/16/2001 | CA2206602C Sequential delivery of purified biological and chemical reagents |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA1341170C Calcium channel compositions and methods |
| 01/14/2001 | CA2313869A1 Genotyping biallelic markers |
| 01/11/2001 | WO2001002866A1 Diagnostics and therapeutics for arterial wall disruptive disorders |
| 01/11/2001 | WO2001002862A1 Methods to detect protein trafficking disorders |
| 01/11/2001 | WO2001002861A1 Detection using dendrimers bearing labels and probes |
| 01/11/2001 | WO2001002860A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
| 01/11/2001 | WO2001002857A1 Measurement and use of molecular interactions |
| 01/11/2001 | WO2001002855A1 Prevention and treatment of amyloid-associated disorders |
| 01/11/2001 | WO2001002850A1 Microfluidic systems and methods for determining modulator kinetics |
| 01/11/2001 | WO2001002828A2 Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
| 01/11/2001 | WO2001002827A2 Biosensor |
| 01/11/2001 | WO2001002609A2 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | WO2001002607A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | WO2001002606A2 Genetic test to determine non-responsiveness to statin drug treatment |
| 01/11/2001 | WO2001002605A1 Method for identifying a compound that modulates the function of the gene product of an essential gene |
| 01/11/2001 | WO2001002604A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | WO2001002603A1 Diagnostic method for squamous cell carcinoma |
| 01/11/2001 | WO2001002602A2 Nucleotides for cycle sequencing of gc-rich templates |
| 01/11/2001 | WO2001002600A2 Detection of analytes using attenuated enzymes |
| 01/11/2001 | WO2001002599A2 Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof |
| 01/11/2001 | WO2001002598A2 Screening for compounds modulating mitochondrial proton leak |
| 01/11/2001 | WO2001002593A2 Control of gene expression in eukaryotic cells |
| 01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | WO2001002583A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 01/11/2001 | WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002568A2 Human genes and gene expression products |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002562A1 Placental organic anion transporter and gene thereof |
| 01/11/2001 | WO2001002561A2 Mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | WO2001002559A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | WO2001002558A1 Probe for analysis of nucleic acids |
| 01/11/2001 | WO2001002557A1 Neurotrophic factor receptor |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002549A2 Homomeric and heteromeric ampa receptors |
| 01/11/2001 | WO2001002538A1 Substrates for nucleic acid immobilization onto solid supports |
| 01/11/2001 | WO2001002436A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | WO2001002430A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 01/11/2001 | WO2001002093A2 Detection article having fluid control film with capillary channels |
| 01/11/2001 | WO2001001998A2 Treatment of endometriosis with antileukoprotease |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001767A1 Hydrocephaly model animals |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000066707A8 Novel thiamine transporter, a polynucleotide encoding same and their uses |
| 01/11/2001 | WO2000066604A3 L-ribo-lna analogues |
| 01/11/2001 | WO2000061793A3 Novel method for identifying antibacterial compounds |
| 01/11/2001 | WO2000061167A3 TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000053738A3 Methods and compositions for regulating memory consolidation |
| 01/11/2001 | WO2000053216A3 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000037679A3 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | DE19923182A1 New primers for detecting T1-like phages, useful for early detection of contamination in Escherichia coli cultures, are derived from the adenine-N6-methyl transferase gene |
| 01/11/2001 | CA2590625A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phospho-transferase system proteins |
| 01/11/2001 | CA2383943A1 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377932A1 Control of gene expression in eukaryotic cells |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377804A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 01/11/2001 | CA2377795A1 Use of the krit1 gene in angiogenesis |
| 01/11/2001 | CA2377780A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | CA2377768A1 Method of identifying toxic agents using differential gene expression |
| 01/11/2001 | CA2377684A1 Screening method |
| 01/11/2001 | CA2377665A1 Methods and compositions for assaying analytes |
| 01/11/2001 | CA2377382A1 Prevention and treatment of amyloid-associated disorders |
| 01/11/2001 | CA2377378A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phosphotransferase system proteins |
| 01/11/2001 | CA2376619A1 Detection using dendrimers bearing labels and probes |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2374386A1 Plant proteins |
| 01/11/2001 | CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | CA2369794A1 Measurement and use of molecular interactions |
| 01/10/2001 | EP1067384A2 Sample detection to initiate timing of an electrochemical assay |
| 01/10/2001 | EP1067199A1 Method of counting microorganisms and device for accomplishing the counting |
| 01/10/2001 | EP1067198A1 Method to determine the process stability of enzymes |
| 01/10/2001 | EP1067179A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/10/2001 | EP1067142A1 Antibody against cleavage product of vimentin |
| 01/10/2001 | EP1067134A2 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system |
| 01/10/2001 | EP1066551A2 Multi-site reactor system with dynamic, independent control of individual reaction sites |
| 01/10/2001 | EP1066517A1 Cellular arrays for rapid molecular profiling |